Widespread use of the blockbuster weight loss drug Ozempic has opened a new area of concern for people preparing for an operation.
The concern arises because Ozempic and other GLP-1 drugs in its class tend to slow the rate at which the stomach empties.
Loading...
Jill Margo is based in the Sydney office. Jill has won multiple prizes, including two Walkley Awards and is an adjunct associate professor at School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. Connect with Jill on Twitter. Email Jill at jmargo@afr.com
